spacer
spacer

PDBsum entry 6cox

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Oxidoreductase PDB id
6cox
Jmol
Contents
Protein chains
552 a.a. *
Ligands
NAG ×6
HEM ×2
S58 ×2
* Residue conservation analysis
HEADER    OXIDOREDUCTASE                          18-DEC-96   6COX
TITLE     CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A SELECTIVE
TITLE    2 INHIBITOR, SC-558 IN I222 SPACE GROUP
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: CYCLOOXYGENASE-2;
COMPND   3 CHAIN: A, B;
COMPND   4 SYNONYM: PROSTAGLANDIN SYNTHASE-2;
COMPND   5 EC: 1.14.99.1;
COMPND   6 ENGINEERED: YES
SOURCE    MOL_ID: 1;
SOURCE   2 ORGANISM_SCIENTIFIC: MUS MUSCULUS;
SOURCE   3 ORGANISM_COMMON: HOUSE MOUSE;
SOURCE   4 ORGANISM_TAXID: 10090;
SOURCE   5 CELL_LINE: CULTURED SF21;
SOURCE   6 TISSUE: DERMAL;
SOURCE   7 CELL: FIBROBLAST;
SOURCE   8 CELLULAR_LOCATION: ENDOPLASMIC RETICULUM;
SOURCE   9 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE  10 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM;
SOURCE  11 EXPRESSION_SYSTEM_TAXID: 7108;
SOURCE  12 EXPRESSION_SYSTEM_CELL_LINE: CULTURED SF21;
SOURCE  13 EXPRESSION_SYSTEM_TISSUE: OVARIAN TISSUE;
SOURCE  14 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS;
SOURCE  15 EXPRESSION_SYSTEM_VECTOR: PVL1393
KEYWDS    PEROXIDASE, DIOXYGENASE, CYCLOOXYGENASE, NONSTEROIDAL
KEYWDS   2 ANTIINFLAMMATORY DRUGS, INFLAMMATION, ARTHRITIS, PROSTAGLANDIN,
KEYWDS   3 PROSTAGLANDIN SYNTHASE, OXIDOREDUCTASE
EXPDTA    X-RAY DIFFRACTION
AUTHOR    R.KURUMBAIL,W.STALLINGS
REVDAT   4   13-JUL-11 6COX    1       VERSN
REVDAT   3   24-FEB-09 6COX    1       VERSN
REVDAT   2   01-APR-03 6COX    1       JRNL
REVDAT   1   24-DEC-97 6COX    0
JRNL        AUTH   R.G.KURUMBAIL,A.M.STEVENS,J.K.GIERSE,J.J.MCDONALD,
JRNL        AUTH 2 R.A.STEGEMAN,J.Y.PAK,D.GILDEHAUS,J.M.MIYASHIRO,T.D.PENNING,
JRNL        AUTH 3 K.SEIBERT,P.C.ISAKSON,W.C.STALLINGS
JRNL        TITL   STRUCTURAL BASIS FOR SELECTIVE INHIBITION OF
JRNL        TITL 2 CYCLOOXYGENASE-2 BY ANTI-INFLAMMATORY AGENTS.
JRNL        REF    NATURE                        V. 384   644 1996
JRNL        REFN                   ISSN 0028-0836
JRNL        PMID   8967954
JRNL        DOI    10.1038/384644A0
REMARK   1
REMARK   1 REFERENCE 1
REMARK   1  AUTH   R.G.KURUMBAIL,A.M.STEVENS,J.K.GIERSE,J.J.MCDONALD,
REMARK   1  AUTH 2 R.A.STEGEMAN,J.Y.PAK,D.GILDEHAUS,J.M.MIYASHIRO,T.D.PENNING,
REMARK   1  AUTH 3 K.SEIBERT,P.C.ISAKSON,W.C.STALLINGS
REMARK   1  TITL   ERRATUM. STRUCTURAL BASIS FOR SELECTIVE INHIBITION OF
REMARK   1  TITL 2 CYCLOOXYGENASE-2 BY ANTI-INFLAMMATORY AGENTS
REMARK   1  REF    NATURE                        V. 385   555 1997
REMARK   1  REFN                   ISSN 0028-0836
REMARK   2
REMARK   2 RESOLUTION.    2.80 ANGSTROMS.
REMARK   3
REMARK   3 REFINEMENT.
REMARK   3   PROGRAM     : X-PLOR 3.1
REMARK   3   AUTHORS     : BRUNGER
REMARK   3
REMARK   3  DATA USED IN REFINEMENT.
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 8.00
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 2.000
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : 100000.000
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : 0.1000
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 88.5
REMARK   3   NUMBER OF REFLECTIONS             : 31066
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT.
REMARK   3   CROSS-VALIDATION METHOD          : NULL
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM
REMARK   3   R VALUE            (WORKING SET) : 0.220
REMARK   3   FREE R VALUE                     : 0.309
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 8.900
REMARK   3   FREE R VALUE TEST SET COUNT      : 3110
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : NULL
REMARK   3
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.
REMARK   3   TOTAL NUMBER OF BINS USED           : 8
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.80
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.92
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 67.80
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : 2651
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2770
REMARK   3   BIN FREE R VALUE                    : 0.3460
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 6.90
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 301
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK   3
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK   3   PROTEIN ATOMS            : 8946
REMARK   3   NUCLEIC ACID ATOMS       : 0
REMARK   3   HETEROGEN ATOMS          : 222
REMARK   3   SOLVENT ATOMS            : 0
REMARK   3
REMARK   3  B VALUES.
REMARK   3   FROM WILSON PLOT           (A**2) : NULL
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 20.60
REMARK   3   OVERALL ANISOTROPIC B VALUE.
REMARK   3    B11 (A**2) : NULL
REMARK   3    B22 (A**2) : NULL
REMARK   3    B33 (A**2) : NULL
REMARK   3    B12 (A**2) : NULL
REMARK   3    B13 (A**2) : NULL
REMARK   3    B23 (A**2) : NULL
REMARK   3
REMARK   3  ESTIMATED COORDINATE ERROR.
REMARK   3   ESD FROM LUZZATI PLOT        (A) : NULL
REMARK   3   ESD FROM SIGMAA              (A) : NULL
REMARK   3   LOW RESOLUTION CUTOFF        (A) : NULL
REMARK   3
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : NULL
REMARK   3   ESD FROM C-V SIGMAA          (A) : NULL
REMARK   3
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.
REMARK   3   BOND LENGTHS                 (A) : 0.014
REMARK   3   BOND ANGLES            (DEGREES) : 1.83
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : NULL
REMARK   3   IMPROPER ANGLES        (DEGREES) : 1.67
REMARK   3
REMARK   3  ISOTROPIC THERMAL MODEL : NULL
REMARK   3
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA
REMARK   3   MAIN-CHAIN BOND              (A**2) : 1.500 ; 2.730
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 2.000 ; 3.000
REMARK   3   SIDE-CHAIN BOND              (A**2) : 2.000 ; 2.730
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 2.500 ; 3.000
REMARK   3
REMARK   3  NCS MODEL : RESTRAINED
REMARK   3
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT
REMARK   3   GROUP  1  POSITIONAL            (A) : 300   ; 0.049
REMARK   3   GROUP  1  B-FACTOR           (A**2) : 1.0   ; 2.02
REMARK   3   GROUP  2  POSITIONAL            (A) : 300   ; 0.038
REMARK   3   GROUP  2  B-FACTOR           (A**2) : 1.0   ; 1.94
REMARK   3   GROUP  3  POSITIONAL            (A) : 300   ; 0.047
REMARK   3   GROUP  3  B-FACTOR           (A**2) : 1.0   ; 2.14
REMARK   3   GROUP  4  POSITIONAL            (A) : 300   ; 0.055
REMARK   3   GROUP  4  B-FACTOR           (A**2) : 1.0   ; 2.55
REMARK   3   GROUP  5  POSITIONAL            (A) : 300   ; 0.042
REMARK   3   GROUP  5  B-FACTOR           (A**2) : 1.0   ; 2.05
REMARK   3   GROUP  6  POSITIONAL            (A) : 300   ; 0.041
REMARK   3   GROUP  6  B-FACTOR           (A**2) : 1.0   ; 1.55
REMARK   3   GROUP  7  POSITIONAL            (A) : 200   ; 0.058
REMARK   3   GROUP  7  B-FACTOR           (A**2) : 2.0   ; 2.68
REMARK   3   GROUP  8  POSITIONAL            (A) : 50    ; 0.18
REMARK   3   GROUP  8  B-FACTOR           (A**2) : 5.0   ; 5.09
REMARK   3
REMARK   3  PARAMETER FILE  1  : PARAM_ENGH.PRO
REMARK   3  PARAMETER FILE  2  : PARAM19X_MOD.HEME
REMARK   3  PARAMETER FILE  3  : PARAM3_MOD.CHO
REMARK   3  PARAMETER FILE  4  : PARAM.SC558
REMARK   3  PARAMETER FILE  5  : NULL
REMARK   3  TOPOLOGY FILE  1   : TOP_ENGH.PRO
REMARK   3  TOPOLOGY FILE  2   : TOPH19X_MOD.HEME
REMARK   3  TOPOLOGY FILE  3   : TOPH3.CHO
REMARK   3  TOPOLOGY FILE  4   : TOP.SC558
REMARK   3  TOPOLOGY FILE  5   : NULL
REMARK   3
REMARK   3  OTHER REFINEMENT REMARKS: NULL
REMARK   4
REMARK   4 6COX COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK 200  DATE OF DATA COLLECTION        : APR-96
REMARK 200  TEMPERATURE           (KELVIN) : 113
REMARK 200  PH                             : 8.0
REMARK 200  NUMBER OF CRYSTALS USED        : 1
REMARK 200
REMARK 200  SYNCHROTRON              (Y/N) : N
REMARK 200  RADIATION SOURCE               : ROTATING ANODE
REMARK 200  BEAMLINE                       : NULL
REMARK 200  X-RAY GENERATOR MODEL          : RIGAKU RUH2R
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.5418
REMARK 200  MONOCHROMATOR                  : NULL
REMARK 200  OPTICS                         : SUPPER MIRRORS
REMARK 200
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE
REMARK 200  DETECTOR MANUFACTURER          : MARRESEARCH
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK
REMARK 200
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 35324
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.800
REMARK 200  RESOLUTION RANGE LOW       (A) : 40.000
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : -0.500
REMARK 200
REMARK 200 OVERALL.
REMARK 200  COMPLETENESS FOR RANGE     (%) : 96.9
REMARK 200  DATA REDUNDANCY                : 4.350
REMARK 200  R MERGE                    (I) : 0.08800
REMARK 200  R SYM                      (I) : 0.08800
REMARK 200   FOR THE DATA SET  : 11.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.81
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.91
REMARK 200  COMPLETENESS FOR SHELL     (%) : 92.7
REMARK 200  DATA REDUNDANCY IN SHELL       : 3.10
REMARK 200  R MERGE FOR SHELL          (I) : 0.32600
REMARK 200  R SYM FOR SHELL            (I) : 0.32600
REMARK 200   FOR SHELL         : 2.160
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: NULL
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MERLOT
REMARK 200 STARTING MODEL: PROSTAGLANDIN SYNTHASE-1, PDB ENTRY 1PRH
REMARK 200
REMARK 200 REMARK: PGHS-1 DIMER WAS USED AS THE SEARCH MODEL.
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS   (%): 52.00
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 20 MM SODIUM PHOSPHATE, 100 MM NACL,
REMARK 280  0.6% BETA- OCTYLGLUCOSIDE, 10 MG/ML PROTEIN, 1MM INHIBITOR MIXED
REMARK 280  WITH A RESERVOIR SOLUTION CONTAINING 20-34% MONOMETHYL PEG 550,
REMARK 280  10-240 MGCL2, 50 MM EPPS PH 8.0 IN THE RATIO OF 1:1
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2
REMARK 290
REMARK 290      SYMOP   SYMMETRY
REMARK 290     NNNMMM   OPERATOR
REMARK 290       1555   X,Y,Z
REMARK 290       2555   -X,-Y,Z
REMARK 290       3555   -X,Y,-Z
REMARK 290       4555   X,-Y,-Z
REMARK 290       5555   X+1/2,Y+1/2,Z+1/2
REMARK 290       6555   -X+1/2,-Y+1/2,Z+1/2
REMARK 290       7555   -X+1/2,Y+1/2,-Z+1/2
REMARK 290       8555   X+1/2,-Y+1/2,-Z+1/2
REMARK 290
REMARK 290     WHERE NNN -> OPERATOR NUMBER
REMARK 290           MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000        0.00000
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000        0.00000
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000
REMARK 290   SMTRY1   5  1.000000  0.000000  0.000000       90.58500
REMARK 290   SMTRY2   5  0.000000  1.000000  0.000000       66.40500
REMARK 290   SMTRY3   5  0.000000  0.000000  1.000000       61.37000
REMARK 290   SMTRY1   6 -1.000000  0.000000  0.000000       90.58500
REMARK 290   SMTRY2   6  0.000000 -1.000000  0.000000       66.40500
REMARK 290   SMTRY3   6  0.000000  0.000000  1.000000       61.37000
REMARK 290   SMTRY1   7 -1.000000  0.000000  0.000000       90.58500
REMARK 290   SMTRY2   7  0.000000  1.000000  0.000000       66.40500
REMARK 290   SMTRY3   7  0.000000  0.000000 -1.000000       61.37000
REMARK 290   SMTRY1   8  1.000000  0.000000  0.000000       90.58500
REMARK 290   SMTRY2   8  0.000000 -1.000000  0.000000       66.40500
REMARK 290   SMTRY3   8  0.000000  0.000000 -1.000000       61.37000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 10420 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 41210 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465   M RES C SSSEQI
REMARK 465     ASP A   584
REMARK 465     PRO A   585
REMARK 465     GLN A   586
REMARK 465     PRO A   587
REMARK 465     THR A   588
REMARK 465     LYS A   589
REMARK 465     THR A   590
REMARK 465     ALA A   591
REMARK 465     THR A   592
REMARK 465     ILE A   593
REMARK 465     ASN A   594
REMARK 465     ALA A   595
REMARK 465     SER A   596
REMARK 465     ALA A   597
REMARK 465     SER A   598
REMARK 465     HIS A   599
REMARK 465     SER A   600
REMARK 465     ARG A   601
REMARK 465     LEU A   602
REMARK 465     ASP A   603
REMARK 465     ASP A   604
REMARK 465     ILE A   605
REMARK 465     ASN A   606
REMARK 465     PRO A   607
REMARK 465     THR A   608
REMARK 465     VAL A   609
REMARK 465     LEU A   610
REMARK 465     ILE A   611
REMARK 465     LYS A   612
REMARK 465     ARG A   613
REMARK 465     ARG A   614
REMARK 465     SER A   615
REMARK 465     THR A   616
REMARK 465     GLU A   617
REMARK 465     LEU A   618
REMARK 465     ASP B   584
REMARK 465     PRO B   585
REMARK 465     GLN B   586
REMARK 465     PRO B   587
REMARK 465     THR B   588
REMARK 465     LYS B   589
REMARK 465     THR B   590
REMARK 465     ALA B   591
REMARK 465     THR B   592
REMARK 465     ILE B   593
REMARK 465     ASN B   594
REMARK 465     ALA B   595
REMARK 465     SER B   596
REMARK 465     ALA B   597
REMARK 465     SER B   598
REMARK 465     HIS B   599
REMARK 465     SER B   600
REMARK 465     ARG B   601
REMARK 465     LEU B   602
REMARK 465     ASP B   603
REMARK 465     ASP B   604
REMARK 465     ILE B   605
REMARK 465     ASN B   606
REMARK 465     PRO B   607
REMARK 465     THR B   608
REMARK 465     VAL B   609
REMARK 465     LEU B   610
REMARK 465     ILE B   611
REMARK 465     LYS B   612
REMARK 465     ARG B   613
REMARK 465     ARG B   614
REMARK 465     SER B   615
REMARK 465     THR B   616
REMARK 465     GLU B   617
REMARK 465     LEU B   618
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500  M RES CSSEQI ATM1   RES CSSEQI ATM2   DEVIATION
REMARK 500    HIS B 388   CG    HIS B 388   CD2     0.060
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500  M RES CSSEQI        PSI       PHI
REMARK 500    ARG A  44       16.22     85.69
REMARK 500    PHE A  52      -55.62     77.37
REMARK 500    TYR A  65     -157.89   -115.12
REMARK 500    GLU A  67      -42.81    -28.79
REMARK 500    LEU A  82      -35.25   -178.64
REMARK 500    THR A  88       21.50    -69.49
REMARK 500    VAL A  89      -42.30   -135.28
REMARK 500    HIS A  95     -158.05    -89.59
REMARK 500    PHE A  96       40.17     30.28
REMARK 500    LYS A  97      -34.03    -38.12
REMARK 500    ASN A 104       -8.16    -51.23
REMARK 500    PRO A 128      158.95    -49.33
REMARK 500    THR A 129      -99.90   -119.97
REMARK 500    VAL A 132      -46.38    -28.89
REMARK 500    SER A 138      157.55     48.06
REMARK 500    ASN A 144      100.79    -54.14
REMARK 500    PRO A 154     -172.19    -66.52
REMARK 500    ASP A 157       -7.86    -56.56
REMARK 500    PRO A 172      136.93    -31.39
REMARK 500    ARG A 185      -78.18   -111.33
REMARK 500    ASN A 195     -165.67    -76.36
REMARK 500    PHE A 205      -72.55    -62.40
REMARK 500    LYS A 211       35.47   -144.91
REMARK 500    THR A 212      125.01    -15.15
REMARK 500    HIS A 226       52.13     31.47
REMARK 500    ASP A 249        2.30     56.58
REMARK 500    HIS A 278       38.75    -80.15
REMARK 500    GLN A 284       90.71    -69.38
REMARK 500    VAL A 287      -54.04     57.65
REMARK 500    GLU A 290       -8.47    -58.24
REMARK 500    PHE A 292       -1.50    -58.55
REMARK 500    HIS A 309      -72.54    -46.27
REMARK 500    GLN A 318       32.38    -93.19
REMARK 500    ASP A 325      -70.78    -52.58
REMARK 500    PHE A 329      -78.96    -54.76
REMARK 500    GLN A 330      -33.95    -39.60
REMARK 500    VAL A 344      -29.78    -39.24
REMARK 500    ASP A 347      -85.15   -108.71
REMARK 500    TYR A 348      -86.73    -29.80
REMARK 500    LEU A 352      -15.42    -46.11
REMARK 500    LEU A 359      154.22    -49.35
REMARK 500    GLU A 364       -4.38    -59.49
REMARK 500    PHE A 371      139.77   -179.17
REMARK 500    TRP A 387       49.99    -82.54
REMARK 500    ILE A 397       66.75   -103.54
REMARK 500    GLU A 398      109.15     20.78
REMARK 500    ASP A 399       27.53     92.20
REMARK 500    LYS A 405      -35.92    -39.82
REMARK 500    TYR A 409       51.81     36.51
REMARK 500    SER A 412      -72.03    -31.59
REMARK 500
REMARK 500 THIS ENTRY HAS     139 RAMACHANDRAN OUTLIERS.
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CHIRAL CENTERS
REMARK 500
REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL
REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY
REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR
REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE
REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16)
REMARK 500
REMARK 500  M RES CSSEQI    IMPROPER   EXPECTED   FOUND DETAILS
REMARK 500    LYS A 137        24.7      L          L   OUTSIDE RANGE
REMARK 500    VAL A 287        21.6      L          L   OUTSIDE RANGE
REMARK 500    ASP A 453        24.1      L          L   OUTSIDE RANGE
REMARK 500    LYS A 459        24.6      L          L   OUTSIDE RANGE
REMARK 500    LYS B 137        24.3      L          L   OUTSIDE RANGE
REMARK 500    VAL B 287        22.3      L          L   OUTSIDE RANGE
REMARK 500    ASP B 453        22.9      L          L   OUTSIDE RANGE
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR:  M RES CSSEQI METAL
REMARK 620                             HEM A 682  FE
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 HIS A 388   NE2
REMARK 620 2 HEM A 682   NA   91.1
REMARK 620 3 HEM A 682   NB   88.0  91.1
REMARK 620 4 HEM A 682   NC   90.3 178.5  89.7
REMARK 620 5 HEM A 682   ND   97.3  89.6 174.6  89.5
REMARK 620 N                    1     2     3     4
REMARK 620
REMARK 620 COORDINATION ANGLES FOR:  M RES CSSEQI METAL
REMARK 620                             HEM B 682  FE
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 HIS B 388   NE2
REMARK 620 2 HEM B 682   NA   92.8
REMARK 620 3 HEM B 682   NB   90.7  90.5
REMARK 620 4 HEM B 682   NC   88.6 178.6  89.4
REMARK 620 5 HEM B 682   ND   94.0  90.2 175.2  89.8
REMARK 620 N                    1     2     3     4
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: CAT
REMARK 800 EVIDENCE_CODE: UNKNOWN
REMARK 800 SITE_DESCRIPTION: TYR 385 IS BELIEVED TO BE THE AMINO ACID THAT
REMARK 800  ABSTRACTS A HYDROGEN ATOM FROM THE SUBSTRATE. IT IS LOCATED CLOSE
REMARK 800  TO THE HEME. A TYROSINE RADICAL IS FORMED DURING THE COURSE OF
REMARK 800  THE REACTION.
REMARK 800
REMARK 800 SITE_IDENTIFIER: ACE
REMARK 800 EVIDENCE_CODE: UNKNOWN
REMARK 800 SITE_DESCRIPTION: SER 530 IS ACETYLATED BY ASPIRIN (AN ACETYL
REMARK 800  GROUP IS COVALENTLY ATTACHED TO THE PROTEIN WHEN INHIBITED WITH
REMARK 800  ASPIRIN). THE ACETYLATED SER PREVENTS THE PROPER BINDING OF THE
REMARK 800  SUBSTRATE IN THE CYCLOOXYGENASE ACTIVE SITE. IT HAS BEEN RECENTLY
REMARK 800  SHOWN, HOWEVER, THAT ACETYLATION OF CYCLOOXYGENASE-2 RESULTS IN
REMARK 800  THE FORMATION OF A DIFFERENT PRODUCT (15-HETE).
REMARK 800
REMARK 800 SITE_IDENTIFIER: HEM
REMARK 800 EVIDENCE_CODE: UNKNOWN
REMARK 800 SITE_DESCRIPTION: HIS 388 IS THE AXIAL LIGAND TO THE HEME.
REMARK 800
REMARK 800 SITE_IDENTIFIER: SUB
REMARK 800 EVIDENCE_CODE: UNKNOWN
REMARK 800 SITE_DESCRIPTION: ARGININE 120 IS BELIEVED TO ANCHOR THE
REMARK 800  CARBOXYLATE OF THE SUBSTRATE BY FORMING AN ION-PAIR.
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 661
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 671
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 681
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG B 661
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG B 671
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG B 681
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 682
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE S58 A 701
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC9
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 682
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE S58 B 701
DBREF  6COX A   33   618  UNP    Q05769   PGH2_MOUSE      18    604
DBREF  6COX B   33   618  UNP    Q05769   PGH2_MOUSE      18    604
SEQADV 6COX GLN A  310  UNP  Q05769    ASN   296 CONFLICT
SEQADV 6COX LYS A  333  UNP  Q05769    ARG   319 CONFLICT
SEQADV 6COX GLN B  310  UNP  Q05769    ASN   296 CONFLICT
SEQADV 6COX LYS B  333  UNP  Q05769    ARG   319 CONFLICT
SEQRES   1 A  587  ALA ASN PRO CYS CYS SER ASN PRO CYS GLN ASN ARG GLY
SEQRES   2 A  587  GLU CYS MET SER THR GLY PHE ASP GLN TYR LYS CYS ASP
SEQRES   3 A  587  CYS THR ARG THR GLY PHE TYR GLY GLU ASN CYS THR THR
SEQRES   4 A  587  PRO GLU PHE LEU THR ARG ILE LYS LEU LEU LEU LYS PRO
SEQRES   5 A  587  THR PRO ASN THR VAL HIS TYR ILE LEU THR HIS PHE LYS
SEQRES   6 A  587  GLY VAL TRP ASN ILE VAL ASN ASN ILE PRO PHE LEU ARG
SEQRES   7 A  587  SER LEU ILE MET LYS TYR VAL LEU THR SER ARG SER TYR
SEQRES   8 A  587  LEU ILE ASP SER PRO PRO THR TYR ASN VAL HIS TYR GLY
SEQRES   9 A  587  TYR LYS SER TRP GLU ALA PHE SER ASN LEU SER TYR TYR
SEQRES  10 A  587  THR ARG ALA LEU PRO PRO VAL ALA ASP ASP CYS PRO THR
SEQRES  11 A  587  PRO MET GLY VAL LYS GLY ASN LYS GLU LEU PRO ASP SER
SEQRES  12 A  587  LYS GLU VAL LEU GLU LYS VAL LEU LEU ARG ARG GLU PHE
SEQRES  13 A  587  ILE PRO ASP PRO GLN GLY SER ASN MET MET PHE ALA PHE
SEQRES  14 A  587  PHE ALA GLN HIS PHE THR HIS GLN PHE PHE LYS THR ASP
SEQRES  15 A  587  HIS LYS ARG GLY PRO GLY PHE THR ARG GLY LEU GLY HIS
SEQRES  16 A  587  GLY VAL ASP LEU ASN HIS ILE TYR GLY GLU THR LEU ASP
SEQRES  17 A  587  ARG GLN HIS LYS LEU ARG LEU PHE LYS ASP GLY LYS LEU
SEQRES  18 A  587  LYS TYR GLN VAL ILE GLY GLY GLU VAL TYR PRO PRO THR
SEQRES  19 A  587  VAL LYS ASP THR GLN VAL GLU MET ILE TYR PRO PRO HIS
SEQRES  20 A  587  ILE PRO GLU ASN LEU GLN PHE ALA VAL GLY GLN GLU VAL
SEQRES  21 A  587  PHE GLY LEU VAL PRO GLY LEU MET MET TYR ALA THR ILE
SEQRES  22 A  587  TRP LEU ARG GLU HIS GLN ARG VAL CYS ASP ILE LEU LYS
SEQRES  23 A  587  GLN GLU HIS PRO GLU TRP GLY ASP GLU GLN LEU PHE GLN
SEQRES  24 A  587  THR SER LYS LEU ILE LEU ILE GLY GLU THR ILE LYS ILE
SEQRES  25 A  587  VAL ILE GLU ASP TYR VAL GLN HIS LEU SER GLY TYR HIS
SEQRES  26 A  587  PHE LYS LEU LYS PHE ASP PRO GLU LEU LEU PHE ASN GLN
SEQRES  27 A  587  GLN PHE GLN TYR GLN ASN ARG ILE ALA SER GLU PHE ASN
SEQRES  28 A  587  THR LEU TYR HIS TRP HIS PRO LEU LEU PRO ASP THR PHE
SEQRES  29 A  587  ASN ILE GLU ASP GLN GLU TYR SER PHE LYS GLN PHE LEU
SEQRES  30 A  587  TYR ASN ASN SER ILE LEU LEU GLU HIS GLY LEU THR GLN
SEQRES  31 A  587  PHE VAL GLU SER PHE THR ARG GLN ILE ALA GLY ARG VAL
SEQRES  32 A  587  ALA GLY GLY ARG ASN VAL PRO ILE ALA VAL GLN ALA VAL
SEQRES  33 A  587  ALA LYS ALA SER ILE ASP GLN SER ARG GLU MET LYS TYR
SEQRES  34 A  587  GLN SER LEU ASN GLU TYR ARG LYS ARG PHE SER LEU LYS
SEQRES  35 A  587  PRO TYR THR SER PHE GLU GLU LEU THR GLY GLU LYS GLU
SEQRES  36 A  587  MET ALA ALA GLU LEU LYS ALA LEU TYR SER ASP ILE ASP
SEQRES  37 A  587  VAL MET GLU LEU TYR PRO ALA LEU LEU VAL GLU LYS PRO
SEQRES  38 A  587  ARG PRO ASP ALA ILE PHE GLY GLU THR MET VAL GLU LEU
SEQRES  39 A  587  GLY ALA PRO PHE SER LEU LYS GLY LEU MET GLY ASN PRO
SEQRES  40 A  587  ILE CYS SER PRO GLN TYR TRP LYS PRO SER THR PHE GLY
SEQRES  41 A  587  GLY GLU VAL GLY PHE LYS ILE ILE ASN THR ALA SER ILE
SEQRES  42 A  587  GLN SER LEU ILE CYS ASN ASN VAL LYS GLY CYS PRO PHE
SEQRES  43 A  587  THR SER PHE ASN VAL GLN ASP PRO GLN PRO THR LYS THR
SEQRES  44 A  587  ALA THR ILE ASN ALA SER ALA SER HIS SER ARG LEU ASP
SEQRES  45 A  587  ASP ILE ASN PRO THR VAL LEU ILE LYS ARG ARG SER THR
SEQRES  46 A  587  GLU LEU
SEQRES   1 B  587  ALA ASN PRO CYS CYS SER ASN PRO CYS GLN ASN ARG GLY
SEQRES   2 B  587  GLU CYS MET SER THR GLY PHE ASP GLN TYR LYS CYS ASP
SEQRES   3 B  587  CYS THR ARG THR GLY PHE TYR GLY GLU ASN CYS THR THR
SEQRES   4 B  587  PRO GLU PHE LEU THR ARG ILE LYS LEU LEU LEU LYS PRO
SEQRES   5 B  587  THR PRO ASN THR VAL HIS TYR ILE LEU THR HIS PHE LYS
SEQRES   6 B  587  GLY VAL TRP ASN ILE VAL ASN ASN ILE PRO PHE LEU ARG
SEQRES   7 B  587  SER LEU ILE MET LYS TYR VAL LEU THR SER ARG SER TYR
SEQRES   8 B  587  LEU ILE ASP SER PRO PRO THR TYR ASN VAL HIS TYR GLY
SEQRES   9 B  587  TYR LYS SER TRP GLU ALA PHE SER ASN LEU SER TYR TYR
SEQRES  10 B  587  THR ARG ALA LEU PRO PRO VAL ALA ASP ASP CYS PRO THR
SEQRES  11 B  587  PRO MET GLY VAL LYS GLY ASN LYS GLU LEU PRO ASP SER
SEQRES  12 B  587  LYS GLU VAL LEU GLU LYS VAL LEU LEU ARG ARG GLU PHE
SEQRES  13 B  587  ILE PRO ASP PRO GLN GLY SER ASN MET MET PHE ALA PHE
SEQRES  14 B  587  PHE ALA GLN HIS PHE THR HIS GLN PHE PHE LYS THR ASP
SEQRES  15 B  587  HIS LYS ARG GLY PRO GLY PHE THR ARG GLY LEU GLY HIS
SEQRES  16 B  587  GLY VAL ASP LEU ASN HIS ILE TYR GLY GLU THR LEU ASP
SEQRES  17 B  587  ARG GLN HIS LYS LEU ARG LEU PHE LYS ASP GLY LYS LEU
SEQRES  18 B  587  LYS TYR GLN VAL ILE GLY GLY GLU VAL TYR PRO PRO THR
SEQRES  19 B  587  VAL LYS ASP THR GLN VAL GLU MET ILE TYR PRO PRO HIS
SEQRES  20 B  587  ILE PRO GLU ASN LEU GLN PHE ALA VAL GLY GLN GLU VAL
SEQRES  21 B  587  PHE GLY LEU VAL PRO GLY LEU MET MET TYR ALA THR ILE
SEQRES  22 B  587  TRP LEU ARG GLU HIS GLN ARG VAL CYS ASP ILE LEU LYS
SEQRES  23 B  587  GLN GLU HIS PRO GLU TRP GLY ASP GLU GLN LEU PHE GLN
SEQRES  24 B  587  THR SER LYS LEU ILE LEU ILE GLY GLU THR ILE LYS ILE
SEQRES  25 B  587  VAL ILE GLU ASP TYR VAL GLN HIS LEU SER GLY TYR HIS
SEQRES  26 B  587  PHE LYS LEU LYS PHE ASP PRO GLU LEU LEU PHE ASN GLN
SEQRES  27 B  587  GLN PHE GLN TYR GLN ASN ARG ILE ALA SER GLU PHE ASN
SEQRES  28 B  587  THR LEU TYR HIS TRP HIS PRO LEU LEU PRO ASP THR PHE
SEQRES  29 B  587  ASN ILE GLU ASP GLN GLU TYR SER PHE LYS GLN PHE LEU
SEQRES  30 B  587  TYR ASN ASN SER ILE LEU LEU GLU HIS GLY LEU THR GLN
SEQRES  31 B  587  PHE VAL GLU SER PHE THR ARG GLN ILE ALA GLY ARG VAL
SEQRES  32 B  587  ALA GLY GLY ARG ASN VAL PRO ILE ALA VAL GLN ALA VAL
SEQRES  33 B  587  ALA LYS ALA SER ILE ASP GLN SER ARG GLU MET LYS TYR
SEQRES  34 B  587  GLN SER LEU ASN GLU TYR ARG LYS ARG PHE SER LEU LYS
SEQRES  35 B  587  PRO TYR THR SER PHE GLU GLU LEU THR GLY GLU LYS GLU
SEQRES  36 B  587  MET ALA ALA GLU LEU LYS ALA LEU TYR SER ASP ILE ASP
SEQRES  37 B  587  VAL MET GLU LEU TYR PRO ALA LEU LEU VAL GLU LYS PRO
SEQRES  38 B  587  ARG PRO ASP ALA ILE PHE GLY GLU THR MET VAL GLU LEU
SEQRES  39 B  587  GLY ALA PRO PHE SER LEU LYS GLY LEU MET GLY ASN PRO
SEQRES  40 B  587  ILE CYS SER PRO GLN TYR TRP LYS PRO SER THR PHE GLY
SEQRES  41 B  587  GLY GLU VAL GLY PHE LYS ILE ILE ASN THR ALA SER ILE
SEQRES  42 B  587  GLN SER LEU ILE CYS ASN ASN VAL LYS GLY CYS PRO PHE
SEQRES  43 B  587  THR SER PHE ASN VAL GLN ASP PRO GLN PRO THR LYS THR
SEQRES  44 B  587  ALA THR ILE ASN ALA SER ALA SER HIS SER ARG LEU ASP
SEQRES  45 B  587  ASP ILE ASN PRO THR VAL LEU ILE LYS ARG ARG SER THR
SEQRES  46 B  587  GLU LEU
MODRES 6COX ASN A   68  ASN  GLYCOSYLATION SITE
MODRES 6COX ASN A  144  ASN  GLYCOSYLATION SITE
MODRES 6COX ASN A  410  ASN  GLYCOSYLATION SITE
MODRES 6COX ASN B   68  ASN  GLYCOSYLATION SITE
MODRES 6COX ASN B  144  ASN  GLYCOSYLATION SITE
MODRES 6COX ASN B  410  ASN  GLYCOSYLATION SITE
HET    NAG  A 661      14
HET    NAG  A 671      14
HET    NAG  A 681      14
HET    NAG  B 661      14
HET    NAG  B 671      14
HET    NAG  B 681      14
HET    HEM  A 682      43
HET    S58  A 701      26
HET    HEM  B 682      43
HET    S58  B 701      26
HETNAM     NAG N-ACETYL-D-GLUCOSAMINE
HETNAM     HEM PROTOPORPHYRIN IX CONTAINING FE
HETNAM     S58 1-PHENYLSULFONAMIDE-3-TRIFLUOROMETHYL-5-
HETNAM   2 S58  PARABROMOPHENYLPYRAZOLE
HETSYN     HEM HEME
FORMUL   3  NAG    6(C8 H15 N O6)
FORMUL   9  HEM    2(C34 H32 FE N4 O4)
FORMUL  10  S58    2(C16 H11 BR F3 N3 O2 S)
HELIX    1   1 PRO A   35  SER A   38  5                                   4
HELIX    2   2 GLN A   42  ARG A   44  5                                   3
HELIX    3   3 PHE A   74  LEU A   80  1                                   7
HELIX    4   4 ASN A   87  THR A   94  1                                   8
HELIX    5   5 LYS A   97  ASN A  105  1                                   9
HELIX    6   6 PRO A  106  LEU A  123  1                                  18
HELIX    7   7 TRP A  139  SER A  143  1                                   5
HELIX    8   8 SER A  174  VAL A  181  1                                   8
HELIX    9   9 MET A  196  PHE A  205  1                                  10
HELIX   10  10 ASN A  231  TYR A  234  1                                   4
HELIX   11  11 LEU A  238  LYS A  243  1                                   6
HELIX   12  12 GLU A  281  LEU A  283  5                                   3
HELIX   13  13 PHE A  292  LEU A  294  5                                   3
HELIX   14  14 PRO A  296  GLU A  319  1                                  24
HELIX   15  15 ASP A  325  GLU A  346  1                                  22
HELIX   16  16 TYR A  348  SER A  353  1                                   6
HELIX   17  17 PRO A  363  LEU A  365  5                                   3
HELIX   18  18 SER A  379  TYR A  385  1                                   7
HELIX   19  19 HIS A  388  LEU A  390  5                                   3
HELIX   20  20 PHE A  404  PHE A  407  1                                   4
HELIX   21  21 ASN A  411  HIS A  417  1                                   7
HELIX   22  22 THR A  420  THR A  427  1                                   8
HELIX   23  23 ALA A  443  GLN A  454  5                                  12
HELIX   24  24 LEU A  463  ARG A  469  1                                   7
HELIX   25  25 PHE A  478  THR A  482  1                                   5
HELIX   26  26 GLU A  486  LEU A  494  1                                   9
HELIX   27  27 ILE A  498  VAL A  500  5                                   3
HELIX   28  28 LEU A  503  VAL A  509  1                                   7
HELIX   29  29 GLU A  520  MET A  535  1                                  16
HELIX   30  30 PRO A  538  CYS A  540  5                                   3
HELIX   31  31 VAL A  554  ASN A  560  1                                   7
HELIX   32  32 ILE A  564  ASN A  571  1                                   8
HELIX   33  33 PRO B   35  SER B   38  5                                   4
HELIX   34  34 PHE B   74  LEU B   80  1                                   7
HELIX   35  35 ASN B   87  THR B   94  1                                   8
HELIX   36  36 LYS B   97  ASN B  105  1                                   9
HELIX   37  37 PRO B  106  LEU B  123  1                                  18
HELIX   38  38 TRP B  139  SER B  143  1                                   5
HELIX   39  39 SER B  174  VAL B  181  1                                   8
HELIX   40  40 MET B  196  PHE B  205  1                                  10
HELIX   41  41 ASN B  231  TYR B  234  1                                   4
HELIX   42  42 LEU B  238  LYS B  243  1                                   6
HELIX   43  43 GLU B  281  LEU B  283  5                                   3
HELIX   44  44 PHE B  292  LEU B  294  5                                   3
HELIX   45  45 PRO B  296  GLU B  319  1                                  24
HELIX   46  46 ASP B  325  GLU B  346  1                                  22
HELIX   47  47 TYR B  348  SER B  353  1                                   6
HELIX   48  48 PRO B  363  LEU B  365  5                                   3
HELIX   49  49 SER B  379  TYR B  385  1                                   7
HELIX   50  50 HIS B  388  LEU B  390  5                                   3
HELIX   51  51 PHE B  404  PHE B  407  1                                   4
HELIX   52  52 ASN B  411  HIS B  417  1                                   7
HELIX   53  53 THR B  420  THR B  427  1                                   8
HELIX   54  54 ALA B  443  GLN B  454  5                                  12
HELIX   55  55 LEU B  463  PHE B  470  1                                   8
HELIX   56  56 PHE B  478  THR B  482  1                                   5
HELIX   57  57 GLU B  486  LEU B  494  1                                   9
HELIX   58  58 ILE B  498  VAL B  500  5                                   3
HELIX   59  59 LEU B  503  VAL B  509  1                                   7
HELIX   60  60 GLU B  520  MET B  535  1                                  16
HELIX   61  61 PRO B  538  CYS B  540  5                                   3
HELIX   62  62 PRO B  547  PHE B  550  5                                   4
HELIX   63  63 VAL B  554  ASN B  560  1                                   7
HELIX   64  64 ILE B  564  ASN B  571  1                                   8
SHEET    1   A 2 GLU A  46  SER A  49  0
SHEET    2   A 2 TYR A  55  ASP A  58 -1  N  ASP A  58   O  GLU A  46
SHEET    1   B 2 GLN A 255  ILE A 257  0
SHEET    2   B 2 GLU A 260  TYR A 262 -1  N  TYR A 262   O  GLN A 255
SHEET    1   C 2 GLU B  46  SER B  49  0
SHEET    2   C 2 TYR B  55  ASP B  58 -1  N  ASP B  58   O  GLU B  46
SHEET    1   D 2 GLN B 255  ILE B 257  0
SHEET    2   D 2 GLU B 260  TYR B 262 -1  N  TYR B 262   O  GLN B 255
SSBOND   1 CYS A   36    CYS A   47                          1555   1555  2.03
SSBOND   2 CYS A   37    CYS A  159                          1555   1555  2.02
SSBOND   3 CYS A   41    CYS A   57                          1555   1555  2.04
SSBOND   4 CYS A   59    CYS A   69                          1555   1555  2.02
SSBOND   5 CYS A  569    CYS A  575                          1555   1555  2.02
SSBOND   6 CYS B   36    CYS B   47                          1555   1555  2.02
SSBOND   7 CYS B   37    CYS B  159                          1555   1555  2.02
SSBOND   8 CYS B   41    CYS B   57                          1555   1555  2.04
SSBOND   9 CYS B   59    CYS B   69                          1555   1555  2.03
SSBOND  10 CYS B  569    CYS B  575                          1555   1555  2.02
LINK        FE   HEM A 682                 NE2 HIS A 388     1555   1555  2.23
LINK         C1  NAG A 661                 ND2 ASN A  68     1555   1555  1.45
LINK         C1  NAG A 671                 ND2 ASN A 144     1555   1555  1.45
LINK         C1  NAG A 681                 ND2 ASN A 410     1555   1555  1.45
LINK        FE   HEM B 682                 NE2 HIS B 388     1555   1555  2.21
LINK         C1  NAG B 661                 ND2 ASN B  68     1555   1555  1.44
LINK         C1  NAG B 671                 ND2 ASN B 144     1555   1555  1.43
LINK         C1  NAG B 681                 ND2 ASN B 410     1555   1555  1.47
CISPEP   1 SER A  126    PRO A  127          0         0.37
CISPEP   2 SER B  126    PRO B  127          0         0.33
SITE     1 CAT  1 TYR A 385
SITE     1 ACE  1 SER A 530
SITE     1 HEM  1 HIS A 388
SITE     1 SUB  1 ARG A 120
SITE     1 AC1  4 PRO A  40  TYR A  55  GLU A  67  ASN A  68
SITE     1 AC2  3 ASN A 144  TYR A 147  ARG A 216
SITE     1 AC3  4 TYR A 402  ASN A 410  SER A 412  ILE A 413
SITE     1 AC4  4 PRO B  40  TYR B  55  GLU B  67  ASN B  68
SITE     1 AC5  4 GLU B 140  ASN B 144  TYR B 147  ARG B 216
SITE     1 AC6  4 TYR B 402  ASN B 410  SER B 412  ILE B 413
SITE     1 AC7 15 ALA A 199  GLN A 203  HIS A 207  PHE A 210
SITE     2 AC7 15 LYS A 211  THR A 212  HIS A 214  VAL A 295
SITE     3 AC7 15 ASN A 382  TYR A 385  HIS A 386  HIS A 388
SITE     4 AC7 15 LEU A 391  VAL A 447  GLN A 454
SITE     1 AC8 16 HIS A  90  ARG A 120  GLN A 192  VAL A 349
SITE     2 AC8 16 LEU A 352  SER A 353  TYR A 355  LEU A 359
SITE     3 AC8 16 TYR A 385  TRP A 387  ALA A 516  PHE A 518
SITE     4 AC8 16 VAL A 523  GLY A 526  ALA A 527  LEU A 531
SITE     1 AC9 14 ALA B 199  GLN B 203  HIS B 207  PHE B 210
SITE     2 AC9 14 LYS B 211  THR B 212  HIS B 214  VAL B 295
SITE     3 AC9 14 ASN B 382  TYR B 385  HIS B 386  HIS B 388
SITE     4 AC9 14 VAL B 447  GLN B 454
SITE     1 BC1 17 HIS B  90  ARG B 120  GLN B 192  VAL B 349
SITE     2 BC1 17 LEU B 352  SER B 353  TYR B 355  LEU B 359
SITE     3 BC1 17 TYR B 385  TRP B 387  ARG B 513  ALA B 516
SITE     4 BC1 17 PHE B 518  VAL B 523  GLY B 526  ALA B 527
SITE     5 BC1 17 LEU B 531
CRYST1  181.170  132.810  122.740  90.00  90.00  90.00 I 2 2 2      16
ORIGX1      1.000000  0.000000  0.000000        0.00000
ORIGX2      0.000000  1.000000  0.000000        0.00000
ORIGX3      0.000000  0.000000  1.000000        0.00000
SCALE1      0.005520  0.000000  0.000000        0.00000
SCALE2      0.000000  0.007530  0.000000        0.00000
SCALE3      0.000000  0.000000  0.008147        0.00000
MTRIX1   1 -0.999600  0.019600 -0.021200       94.38400    1
MTRIX2   1  0.018900 -0.109200 -0.993800       64.06400    1
MTRIX3   1 -0.021800 -0.993800  0.108800       59.22200    1
      
PROCHECK
Go to PROCHECK summary
 References